Real-world study in severe eosinophilic asthma patients refractory to anti-IL5 biological agents treated with benralizumab in Spain (ORBE study) - Martínez-Moragón, E.; García-Moguel, I.; Nuevo, J.; Resler, G.; Antépara, I.; Arismendi-Núñez, E.; Casas-Maldonado, F.; Dávila-González, I.; Velasco-Garrido, J.L.; Díaz-Campos, R.; Díaz-Donado, C.; Gálvez, B.; et al. (Bmc Pulmonary Medicine, 2021)